(Q34291491)

1 August 2017

0 references

Helicobacter pylori and early duodenal ulcer status post-treatment: a review (English)

1 reference

1 August 2017

0 references

Meyer JM

1

1 reference

1 August 2017

Silliman NP

2

1 reference

1 August 2017

Dixon CA

3

1 reference

1 August 2017

Siepman NY

4

1 reference

1 August 2017

Sugg JE

5

1 reference

1 August 2017

Hopkins RJ

6

1 reference

1 August 2017

publication date

1 June 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

6

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

84-92

1 reference

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

An alternative non-macrolide, non-imidazole treatment regimen for curing Helicobacter pylori and duodenal ulcers: ranitidine bismuth citrate plus amoxicillin. The RBC H. pylori Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Necrosis and apoptosis in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

Gastric cytoprotection by amoxycillin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2001.00013.X

10.1046/J.1523-5378.2001.00013.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference